Not Yet RecruitingNCT07671248
Tirzepatide in the Treatment of Addiction
Medication studyAges 18+Canada
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- HamiltonSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: August 1, 2026
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 15
- Sponsor
- McMaster University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Canada
- Age range
- Over 18 Years
- Official registry ID
- NCT07671248
- Official title
Show the full official title
A 12-Week Phase 3 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Tirzepatide-Assisted-Psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept Study
Recruitment & locations
Not yet recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Hamilton
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is McMaster University, a university.
Does this study involve medication?
Yes. The study involves medication, including Tirzepatide.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as not yet recruiting.
